Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors

Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025. 

Show reference: 

https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957